Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BFBMF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
polatuzumab-compound 3-1.75
|
|||||
| Synonyms |
polatuzumab-compound 3-1.75
Click to Show/Hide
|
|||||
| Organization |
R.P. SCHERER TECHNOLOGIES, LLC
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.75
|
|||||
| Structure |
|
|||||
| Antibody Name |
polatuzumab
|
Antibody Info | ||||
| Antigen Name |
B-cell antigen receptor complex-associated protein beta chain (CD79B)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
site-specific conjugation
|
|||||